Cargando…

Immunological Fingerprints of Controllers Developing Neutralizing HIV-1 Antibodies

The induction of broadly neutralizing antibodies (bnAbs) is highly desired for an effective vaccine against HIV-1. Typically, bnAbs develop in patients with high viremia, but they can also evolve in some untreated HIV-1 controllers with low viral loads. Here, we identify a subgroup of neutralizer-co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin-Gayo, Enrique, Gao, Ce, Chen, Hsiao Rong, Ouyang, Zhengyu, Kim, Dhohyung, Kolb, Kellie E., Shalek, Alex K., Walker, Bruce D., Lichterfeld, Mathias, Yu, Xu G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990401/ https://www.ncbi.nlm.nih.gov/pubmed/31995767 http://dx.doi.org/10.1016/j.celrep.2019.12.087

Ejemplares similares

A Reproducibility-Based Computational Framework Identifies an Inducible, Enhanced Antiviral State in Dendritic Cells from HIV-1 Elite Controllers
por: Martin-Gayo, Enrique, et al.
Publicado: (2018)

Cooperation between cGAS and RIG-I sensing pathways enables improved innate recognition of HIV-1 by myeloid dendritic cells in elite controllers
por: Martin-Gayo, Enrique, et al.
Publicado: (2022)

Potent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers
por: Martin-Gayo, Enrique, et al.
Publicado: (2015)

HIV-1 persistence in CD4(+) T cells with stem cell-like properties
por: Buzon, Maria J., et al.
Publicado: (2014)

Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting
por: Doria-Rose, Nicole A., et al.
Publicado: (2017)

Lectin Fingerprinting Distinguishes Antibody Neutralization in SARS-CoV-2
por: Wuo, Michael G., et al.
Publicado: (2023)

P04-26. Immunological tolerance prevents the expression of a broadly reactive neutralizing HIV-1 antibody
por: Verkoczy, L, et al.
Publicado: (2009)

Immunologic characteristics of HIV‐infected individuals who make broadly neutralizing antibodies
por: Borrow, Persephone, et al.
Publicado: (2017)

Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies Against HIV-1
por: Yu, Lei, et al.
Publicado: (2014)

Interactions between HLA-B and leukocyte immunoglobulin like receptors B2 (LILRB2) correlate with HIV-1 disease outcomes
por: Martin Gayo, E, et al.
Publicado: (2012)

Synergistic Induction of Interferon α through TLR-3 and TLR-9 Agonists Identifies CD21 as Interferon α Receptor for the B Cell Response
por: Kim, Dhohyung, et al.
Publicado: (2013)

Immune-profiling of ZIKV-infected patients identifies a distinct function of plasmacytoid dendritic cells for immune cross-regulation
por: Sun, Xiaoming, et al.
Publicado: (2020)

Immunological strategies against spike protein: Neutralizing antibodies and vaccine development for COVID‐19
por: Huang, Jiansheng, et al.
Publicado: (2020)

High-Dimensional Cytometry Dissects Immunological Fingerprints of Idiopathic Inflammatory Myopathies
por: Nelke, Christopher, et al.
Publicado: (2022)

Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data
por: Ferguson, Andrew L., et al.
Publicado: (2013)

NEUTRALIZING ANTIBODIES IN HUMAN SERUM AFTER INFLUENZA A : THE LACK OF STRAIN SPECIFICITY IN THE IMMUNOLOGICAL RESPONSE
por: Horsfall, F. L., et al.
Publicado: (1941)

Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H
por: Fan, Yongfeng, et al.
Publicado: (2016)

Epitope Analysis of Anti-SARS-CoV-2 Neutralizing Antibodies
por: Xue, Jun-biao, et al.
Publicado: (2021)

Immunological fingerprint in coronavirus disease-19 convalescents with and without post-COVID syndrome
por: Augustin, Max, et al.
Publicado: (2023)

Phenotypic signatures of immune selection in HIV-1 reservoir cells
por: Sun, Weiwei, et al.
Publicado: (2023)

Identifying immunologically-vulnerable regions of the HCV E2 glycoprotein and broadly neutralizing antibodies that target them
por: Quadeer, Ahmed A., et al.
Publicado: (2019)

Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies
por: Cotugno, Nicola, et al.
Publicado: (2021)

Broadly Neutralizing Antibodies for HIV Eradication
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

P05-03. The use of immune complexes to enhance antibody responses against neutralizing epitopes on HIV envelope
por: Hioe, CE, et al.
Publicado: (2009)

Antibodies and Brain Disease: A Convergence of Immunology and Physiology
por: Diamond, Betty, et al.
Publicado: (2006)

In Vivo Metabolic Fingerprinting of Neutral Lipids with Hyperspectral Stimulated Raman Scattering Microscopy
por: Fu, Dan, et al.
Publicado: (2014)

Optimization of Electrochemical Visualization of Latent Fingerprints with Poly(Neutral Red) on Brass Surfaces
por: Broncová, Gabriela, et al.
Publicado: (2021)

High-Throughput UV Photoionization and Fragmentation of Neutral Biomolecules as a Structural Fingerprint
por: Wang, Siwen, et al.
Publicado: (2023)

Effective innate immune response in natural HIV-1 controllers. Can mimicking lead to novel preventive and cure strategies against HIV-1?
por: Calvet-Mirabent, Marta, et al.
Publicado: (2022)

Modeling Neutralization Kinetics of HIV by Broadly Neutralizing Monoclonal Antibodies in Genital Secretions Coating the Cervicovaginal Mucosa
por: McKinley, Scott A., et al.
Publicado: (2014)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
por: Landais, Elise, et al.
Publicado: (2018)

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
por: McCoy, Laura E., et al.
Publicado: (2015)

Role of Dendritic Cells in Natural Immune Control of HIV-1 Infection
por: Martin-Gayo, Enrique, et al.
Publicado: (2019)

Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy
por: Sun, Weiwei, et al.
Publicado: (2023)

Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy
por: Sun, Weiwei, et al.
Publicado: (2023)

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
por: Sok, Devin, et al.
Publicado: (2013)

Likely accelerated weakening of Atlantic overturning circulation emerges in optimal salinity fingerprint
por: Zhu, Chenyu, et al.
Publicado: (2023)

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals
por: Clarridge, Katherine E., et al.
Publicado: (2018)

Neutralizing antibodies for orthobunyaviruses in Pantanal, Brazil
por: Pauvolid-Corrêa, Alex, et al.
Publicado: (2017)

Signaling network prediction by the Ontology Fingerprint enhanced Bayesian network
por: Qin, Tingting, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_179d3924gh07r0jfmurdq2f0vo